Finance

Lists
SPRY:NASDAQ
ARS Pharmaceuticals Inc
$5.65
-7.38%
(-0.45) 1D
$5.65
0.00% (0.00)
After hours
Closed: Aug 14, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SPRY...
Open
$5.10
High
$5.84
Low
$5.00
Mkt. cap
561.06M
Avg. vol.
2.12M
Volume
5.05M
52-wk high
$15.08
52-wk low
$4.91
EPS
-$2.00
Beta
0.98
Shares outstanding
99.30M
No. of employees
157
Open
$5.10
High
$5.84
Low
$5.00
Mkt. cap
561.06M
Avg. vol.
2.12M
Volume
5.05M
52-wk high
$15.08
52-wk low
$4.91
EPS
-$2.00
Beta
0.98
Shares outstanding
99.30M
No. of employees
157
News stories
From web sources and news partners
About ARS Pharmaceuticals Inc
CEO-
Employees157
Founded2015
Headquarters-
SectorBiotechnology
Websitears-pharma.com
Analyst ratings
Based on 2 analysts giving stock ratings to SPRY in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for SPRY in the last 3 months.
Highest
Current $5.65
$30.00 (+430.97%)
Average
$30.00 (+430.97%)
Lowest
$30.00 (+430.97%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joshua Schimmer
Cantor Fitzgerald
Buy
Reiterated
$30.00
+431%
08/14/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
08/14/2026
Carl Byrnes
Northland Securities
Buy
Maintained
$25.00
+342.5%
04/15/2026
Kyle Bauser
Roth MKM
Buy
Reiterated
$30.00
+431%
04/14/2026
Ryan Deschner
Raymond James
Buy
Maintained
-
-
01/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
32.50M
28.09M
22.68M
33.66M
Cost of goods sold
10.94M
9.60M
10.62M
-
Cost of revenue
10.94M
9.60M
10.62M
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
74.75M
59.96M
72.20M
-
Operating expense
74.75M
59.96M
72.20M
-
Total operating expenses
85.69M
69.55M
82.83M
-
Operating income
-53.19M
-41.46M
-60.14M
-
Other non operating income
2.04M
-3.49M
-
-
EBT including unusual items
-51.15M
-41.40M
-60.62M
-
EBT excluding unusual items
-51.15M
-36.88M
-60.62M
-
Income tax expense
-
-80.00K
-
-
Effective tax rate
-
0.19%
-
-
Other operating expenses
-
-
-
-
Net income
-51.15M
-41.32M
-60.62M
-
Net profit margin
-157.38%
-147.13%
-267.26%
-
Earnings per share
-0.52
-0.42
-0.61
-0.63
Interest and investment income
-
10.67M
1.97M
-
Interest expense
-
-2.60M
-2.44M
-
Net interest expenses
-
8.07M
-473.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-52.80M
-41.05M
-59.75M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps